Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK
Amber Giles(National Institutes of Health), Deric M. Park(National Cancer Institute)
Cited by 61
Related Papers
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
|Journal for ImmunoTherapy of Cancer|2018|481
The Evidence of Glioblastoma Heterogeneity
|Scientific Reports|2015|212